Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Accumulated Expenses (2022 - 2025)

Historic Accumulated Expenses for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $3.3 million.

  • CervoMed's Accumulated Expenses rose 33931.78% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 33931.78%. This contributed to the annual value of $2.4 million for FY2024, which is 66613.82% up from last year.
  • According to the latest figures from Q3 2025, CervoMed's Accumulated Expenses is $3.3 million, which was up 33931.78% from $2.8 million recorded in Q2 2025.
  • CervoMed's 5-year Accumulated Expenses high stood at $3.3 million for Q3 2025, and its period low was $206675.0 during Q4 2022.
  • In the last 4 years, CervoMed's Accumulated Expenses had a median value of $482162.0 in 2024 and averaged $924505.7.
  • In the last 5 years, CervoMed's Accumulated Expenses plummeted by 5985.51% in 2023 and then soared by 66613.82% in 2024.
  • Quarter analysis of 4 years shows CervoMed's Accumulated Expenses stood at $206675.0 in 2022, then skyrocketed by 49.54% to $309062.0 in 2023, then surged by 666.14% to $2.4 million in 2024, then surged by 37.26% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $2.8 million for Q2 2025, and $385866.0 during Q1 2025.